Industry Insights and Analysis of the Mass Spectrometry Market (2023–2032)
Allied Market Research published a report on the mass spectrometry industry, which offers industry dynamics, including growth drivers, opportunities, and challenges. This report further provides regional analysis and a competitive landscape of the sector. The global industry accounted for $6.9 billion in 2022 and is anticipated to reach $14.6 billion by 2032, at a CAGR of 7.7% from 2023 to 2032.
► Don't Miss Out "Downlo... moreIndustry Insights and Analysis of the Mass Spectrometry Market (2023–2032)
Allied Market Research published a report on the mass spectrometry industry, which offers industry dynamics, including growth drivers, opportunities, and challenges. This report further provides regional analysis and a competitive landscape of the sector. The global industry accounted for $6.9 billion in 2022 and is anticipated to reach $14.6 billion by 2032, at a CAGR of 7.7% from 2023 to 2032.
The mass spectrometry industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. In 2022, North America held a large share of the sector and is expected to remain the leading region during the forecast period. Industry growth in the region is fueled by the presence of key players, such as PerkinElmer, Inc., Thermo Fisher Scientific Inc., and Agilent Technologies, Inc., and well-developed industrial sectors such as biotechnology and pharmaceutical. Moreover, the use of portable and advanced mass spectrometry instruments over traditional mass spectrometers is accelerating the growth of the industry in the region. Asia-Pacific is projected to register the fastest growth during the forecast period.
Important questions and answers
What is mass spectrometry?
For what is mass spectrometry used?
What are the key trends in the industry?
Which are the top companies that hold major share in the market?
What is the total market value of this sector?
Funding support enhances mass spectrometry research
Government funding boosts the growth of the mass spectrometry industry. Governments often provide money to support research in healthcare, life sciences, and the environment. Mass spectrometry is a technology commonly used in areas such as proteomics, metabolomics, medical testing, and environmental analysis. Such government fundings help researchers get the tools, equipment, and support they need to improve mass spectrometry and create new uses for it. These financial aids often support research that turns scientific discoveries into real-world applications.
Expanding role of mass spectrometry in drug discovery and development
With rise in the number of chronic diseases, the end users, such as pharmaceutical companies, clinical labs, and research institutions, are allocating more resources to research and development. The mass spectrometer is helpful in finding new drugs as it gives important information about molecular interactions and protein functions. With increased understanding of diseases at the molecular level, the use of mass spectrometry in drug discovery and development is growing. Advancements in mass spectrometer technology are expected to enhance its ability to detect fine details, making it more useful for analyzing large proteins.
Recent developments
In April 2025, Bruker, a global manufacturer of high-end analytical instruments, announced the acquisition of RECIPE, a company that makes mass spectrometry diagnostic kits. This deal boosts the role of Bruker in therapeutic drug monitoring (TDM). Both the companies are jointly developing the ClinDART triple-quadrupole mass spectrometry platform, which offers high-throughput capabilities and operates without the need for chromatography. This new system is designed to provide reliable and affordable TDM tests, which is making it easier and better for healthcare providers and patients to monitor drug levels.
In December 2024, Roche, a Swiss multinational healthcare company, secured CE certification for the Cobas Mass Spec solution, which includes the cobas i 601 analyzer and the onify reagent kit designed for steroid hormones.
Key industry players
Hiden Analytical Ltd.
Waters Corporation
Kore Technologies, Ltd.
Agilent Technologies, Inc.
Shimadzu Corporation
Thermo Fisher Scientific Inc.
Bruker Corporation
PerkinElmer, Inc.
Danaher Corporation
Leco Corporation
To sum up
The AMR report offers a detailed study of the industry, including a comprehensive competitive landscape. It further highlights emerging trends, key growth drivers, and potential opportunities that empower industry leaders and stakeholders to make informed strategic decisions. The report serves as a valuable resource for understanding changes in the domain, mitigating risks, and supporting long-term business growth in an increasingly competitive environment by offering in-depth insights.
